Skip to main content
Erschienen in: Reactions Weekly 1/2020

01.07.2020 | Case report

Antivirals/direct oral anticoagulants interaction

Anticoagulation drug level increased and off label use: 12 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
  • * Drug interaction
Literatur
Zurück zum Zitat Testa S, et al. Direct oral anticoagulant plasma levels' striking increase in severe COVID-19 respiratory syndrome patients treated with antiviral agents: The Cremona experience. Journal of Thrombosis and Haemostasis 18: 1320-1323, No. 6, Jun 2020. Available from: URL: http://doi.org/10.1111/jth.14871 Testa S, et al. Direct oral anticoagulant plasma levels' striking increase in severe COVID-19 respiratory syndrome patients treated with antiviral agents: The Cremona experience. Journal of Thrombosis and Haemostasis 18: 1320-1323, No. 6, Jun 2020. Available from: URL: http://​doi.​org/​10.​1111/​jth.​14871
Metadaten
Titel
Antivirals/direct oral anticoagulants interaction
Anticoagulation drug level increased and off label use: 12 case reports
Publikationsdatum
01.07.2020
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-80277-x

Weitere Artikel der Ausgabe 1/2020

Reactions Weekly 1/2020 Zur Ausgabe

Case report

Warfarin

Case report

Atezolizumab

Case report

Adalimumab

Case report

Epoprostenol